Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 01:15PM GMT
Release Date Price: $238.2 (+10.34%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right, good morning and once again, welcome to the 40th Annual, and unfortunately second time virtual, JPMorgan Health Care Conference. My name is Cory Kasimov, I'm the senior large cap biotech analyst, and it's my pleasure to introduce Moderna and CEO, Stéphane Bancel, who really needs no introduction.

Please note that following this presentation, we will move right into a Q&A session where you can send in questions via the little blue Ask a Question button on your conference portal. And if it's easier, you can also e-mail me questions as well, and we'll do our best to work them into the conversation.

So with that, Stéphane, thank you for being here. Let me turn it over to you.

Stephane Bancel
Moderna, Inc. - CEO & Director

Well, thank you, Cory. Good morning, good afternoon or good evening, everyone, and happy new year to everybody. Wishing you a healthy and happy year.

So let me start by reminding everybody we'll be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot